# NWI MANAGEMENT LP

> Institutional holdings reported to the SEC as of Q2 2026 on Form 13F. CIK 1103887. Source: https://holderbook.com/funds/1103887-nwi-management-lp/

- Reported value: $2.2B
- Positions: 50
- Weight of the ten largest: 65.5%
- Filed: 2026-08-14

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| INVESCO QQQ TR | [QQQ](https://holderbook.com/stocks/QQQ/) | $220.9M | 0 | 10.2% | 3 |
| NATERA INC | [NTRA](https://holderbook.com/stocks/NTRA/) | $207.0M | 762,603 | 9.6% | 9 |
| VANECK ETF TRUST | [SMH](https://holderbook.com/stocks/SMH/) | $198.7M | 3,000 | 9.2% | 9 |
| MICRON TECHNOLOGY INC | [MU](https://holderbook.com/stocks/MU/) | $155.1M | 134,400 | 7.2% | 26 |
| META PLATFORMS INC | [META](https://holderbook.com/stocks/META/) | $129.0M | 198,000 | 6.0% | 26 |
| APPLE INC | [AAPL](https://holderbook.com/stocks/AAPL/) | $108.8M | 376,100 | 5.0% | 10 |
| INSMED INC | [INSM](https://holderbook.com/stocks/INSM/) | $108.1M | 1,014,000 | 5.0% | 8 |
| ALPHABET INC | [GOOG](https://holderbook.com/stocks/GOOG/) | $102.5M | 290,000 | 4.7% | 26 |
| NU HLDGS LTD | [NU](https://holderbook.com/stocks/NU/) | $94.0M | 7,039,000 | 4.4% | 5 |
| TAIWAN SEMICONDUCTOR MANUFAC | [TSM](https://holderbook.com/stocks/TSM/) | $90.3M | 189,000 | 4.2% | 3 |
| SELECT SECTOR SPDR TR | [XLV](https://holderbook.com/stocks/XLV/) | $89.6M | 565,000 | 4.1% | 12 |
| SPDR GOLD TR | [GLD](https://holderbook.com/stocks/GLD/) | $81.4M | 5,000 | 3.8% | 11 |
| ISHARES INC | [EWY](https://holderbook.com/stocks/EWY/) | $62.4M | 9,000 | 2.9% | 2 |
| INTERCORP FINL SVCS INC | [IFS](https://holderbook.com/stocks/IFS/) | $57.3M | 1,022,210 | 2.7% | 27 |
| TESLA INC | [TSLA](https://holderbook.com/stocks/TSLA/) | $41.6M | 49,000 | 1.9% | 19 |
| NVIDIA CORPORATION | [NVDA](https://holderbook.com/stocks/NVDA/) | $36.8M | 184,000 | 1.7% | 19 |
| BECTON DICKINSON &amp; CO | [BDX](https://holderbook.com/stocks/BDX/) | $34.0M | 225,000 | 1.6% | 2 |
| REVOLUTION MEDICINES INC | [RVMD](https://holderbook.com/stocks/RVMD/) | $33.7M | 180,000 | 1.6% | 1 |
| PALO ALTO NETWORKS INC | [PANW](https://holderbook.com/stocks/PANW/) | $30.7M | 90,000 | 1.4% | 29 |
| RTX CORPORATION | [RTX](https://holderbook.com/stocks/RTX/) | $23.9M | 126,000 | 1.1% | 4 |
| NEWAMSTERDAM PHARMA COMPANY | [NAMS](https://holderbook.com/stocks/NAMS/) | $23.8M | 702,000 | 1.1% | 1 |
| MICROSOFT CORP | [MSFT](https://holderbook.com/stocks/MSFT/) | $23.3M | 62,500 | 1.1% | 28 |
| AMAZON COM INC | [AMZN](https://holderbook.com/stocks/AMZN/) | $20.7M | 87,000 | 1.0% | 4 |
| JPMORGAN CHASE &amp; CO | [JPM](https://holderbook.com/stocks/JPM/) | $18.0M | 55,000 | 0.8% | 25 |
| FIGURE TECHNOLOGY SOLUTIO | [FIGR](https://holderbook.com/stocks/FIGR/) | $18.0M | 585,000 | 0.8% | 4 |
| NORTHROP GRUMMAN CORP | [NOC](https://holderbook.com/stocks/NOC/) | $15.8M | 31,100 | 0.7% | 2 |
| ORACLE CORP | [ORCL](https://holderbook.com/stocks/ORCL/) | $14.7M | 100,000 | 0.7% | 3 |
| LOCKHEED MARTIN CORP | [LMT](https://holderbook.com/stocks/LMT/) | $13.8M | 27,000 | 0.6% | 4 |
| WALMART INC | [WMT](https://holderbook.com/stocks/WMT/) | $13.6M | 120,000 | 0.6% | 24 |
| INVESCO EXCHANGE TRADED FD T | [RSP](https://holderbook.com/stocks/RSP/) | $11.5M | 54,000 | 0.5% | 3 |
| CROWDSTRIKE HLDGS INC | [CRWD](https://holderbook.com/stocks/CRWD/) | $11.4M | 15,000 | 0.5% | 10 |
| ISHARES TR | [INDA](https://holderbook.com/stocks/INDA/) | $10.4M | 210,000 | 0.5% | 11 |
| ABIVAX SA | [ABVX](https://holderbook.com/stocks/ABVX/) | $9.6M | 72,000 | 0.4% | 1 |
| COGENT BIOSCIENCES INC | [COGT](https://holderbook.com/stocks/COGT/) | $9.4M | 241,671 | 0.4% | 3 |
| WATERS CORP | [WAT](https://holderbook.com/stocks/WAT/) | $7.3M | 19,489 | 0.3% | 2 |
| GRUPO FINANCIERO GALICIA S.A | [GGAL](https://holderbook.com/stocks/GGAL/) | $5.0M | 99,312 | 0.2% | 8 |
| ASTRAZENECA PLC | [AZN](https://holderbook.com/stocks/AZN/) | $4.7M | 25,000 | 0.2% | 1 |
| ALIBABA GROUP HLDG LTD | [BABA](https://holderbook.com/stocks/BABA/) | $4.3M | 45,000 | 0.2% | 28 |
| ISHARES SILVER TR | [SLV](https://holderbook.com/stocks/SLV/) | $3.5M | 65,000 | 0.2% | 24 |
| NEWMONT CORP | [NEM](https://holderbook.com/stocks/NEM/) | $2.1M | 22,500 | 0.1% | 1 |
| VISTRA CORP | [VST](https://holderbook.com/stocks/VST/) | $2.0M | 12,600 | 0.1% | 1 |
| JONES LANG LASALLE INC | [JLL](https://holderbook.com/stocks/JLL/) | $2.0M | 6,300 | 0.1% | 1 |
| MCDONALDS CORP | [MCD](https://holderbook.com/stocks/MCD/) | $1.9M | 7,200 | 0.1% | 1 |
| ELI LILLY &amp; CO | [LLY](https://holderbook.com/stocks/LLY/) | $1.8M | 1,500 | 0.1% | 7 |
| TEVA PHARMACEUTICAL INDS LTD | [TEVA](https://holderbook.com/stocks/TEVA/) | $1.4M | 40,000 | 0.1% | 7 |
| T-MOBILE US INC | [TMUS](https://holderbook.com/stocks/TMUS/) | $1.3M | 8,000 | 0.1% | 31 |
| BANCO BBVA ARGENTINA S A | [BBAR](https://holderbook.com/stocks/BBAR/) | $1.2M | 63,000 | 0.1% | 6 |
| ISHARES ETHEREUM TR | [ETHA](https://holderbook.com/stocks/ETHA/) | $1.2M | 99,000 | 0.1% | 3 |
| GLOBAL X FDS | [ARGT](https://holderbook.com/stocks/ARGT/) | $813.0K | 8,900 | 0.0% | 8 |
| ALLOGENE THERAPEUTICS INC | [ALLO](https://holderbook.com/stocks/ALLO/) | $208.0K | 100,000 | 0.0% | 5 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q2 2026 | +23.5% | +14.8% | +8.6% | 128% |
| Q1 2026 | -5.8% | -4.6% | -1.1% | 80% |
| Q4 2025 | +12.4% | +2.4% | +10.1% | 64% |
| Q2 2025 | +19.1% | +10.5% | +8.7% | 94% |
| Q1 2025 | -8.1% | -4.6% | -3.5% | 64% |
| Q4 2024 | +6.3% | +2.1% | +4.2% | 100% |
| Q3 2024 | +5.6% | +5.4% | +0.1% | 100% |
| Q2 2024 | +11.4% | +4.0% | +7.4% | 100% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q2 2026 | $2.2B | 50 |
| Q1 2026 | $1.8B | 48 |
| Q4 2025 | $2.2B | 50 |
| Q3 2025 | $3.7B | 55 |
| Q2 2025 | $3.8B | 46 |
| Q1 2025 | $796.1M | 43 |
| Q4 2024 | $2.3B | 49 |
| Q3 2024 | $3.8B | 46 |
| Q2 2024 | $2.7B | 39 |
| Q1 2024 | $3.3B | 49 |
| Q4 2023 | $4.0B | 50 |
| Q3 2023 | $2.1B | 48 |

